Begin enrolment for the Phase I/II study in DIPG
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 26 Jan 2021
- Due
- 31 Dec 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Both the Phase I/II study in DIPG and the Phase I pilot study in GBM are expected to begin enrolment later this year”
What we found
Evidence strength A What the grades mean
The company did not begin enrolment for the Phase I/II study in DIPG by the end of 2021, instead planning to initiate a Phase II study in the second half of 2022.
-
A Midatech Pharma Plc 20-F filed 2022-04-26
“We plan to initiate a Phase II study in DIPG in the second half of 2022” ✓ confirmed on the page
-
A Midatech Pharma Plc 6-K filed 2022-04-26
“Accordingly, we have begun has preparations for patient enrolment to begin mid-2022” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Begin
- Deliverable
- Phase I/II study in DIPG
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Midatech Pharma Plc? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-BDRX-022440 · Corrections policy